NIGEL RODNEY: Open Payments
NPI 1023595147 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 39 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $299 |
| Neurocrine BioSciences, Inc. | 4 | $202 |
| Vanda Pharmaceuticals Inc. | 6 | $158 |
| Lundbeck LLC | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, FANAPT, REXULTI, COBENFY.
Industry payments across CT — which companies pay providers there.
